Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Details)

v3.21.1
NET LOSS PER SHARE (Details)
3 Months Ended
Mar. 31, 2021
shares
Warrants | Private Placement  
Subsidiary, Sale of Stock [Line Items]  
Anti-dilutive securities attributable to warrants (in shares) 17,500,000